Daily Respiratory Research Analysis
Analyzed 172 papers and selected 3 impactful papers.
Summary
Three impactful respiratory studies stood out: a multi-system validation showing that bedside electrical impedance tomography (EIT) can accurately detect pulmonary embolism via a novel wasted-ventilation index; a large cystic fibrosis registry analysis linking long-term PM2.5 exposure to worse lung outcomes even in the CFTR modulator era; and a prospective ICU study demonstrating an AI algorithm that noninvasively tracks inspiratory muscle effort and detects ventilator dyssynchrony in real time.
Research Themes
- Point-of-care imaging biomarkers for pulmonary embolism
- Environmental exposures and respiratory disease in the modulator era
- AI-driven monitoring of ventilator mechanics and synchrony
Selected Articles
1. Accuracy of electrical impedance tomography to detect perfusion defects in pulmonary embolism.
Across animal models and human cohorts, an EIT-derived wasted-ventilation index identified pulmonary arterial occlusions with high accuracy and aligned closely with DCE-CT and CTPA. The index also decreased after thrombolysis, suggesting responsiveness to therapy and potential use for bedside monitoring when radiographic imaging is unsafe or unavailable.
Impact: Introduces a validated, bedside physiologic biomarker for PE that could reduce reliance on radiographic imaging in unstable patients and enable dynamic treatment monitoring.
Clinical Implications: EIT with a wasted-ventilation index may support PE diagnosis at the bedside when CTPA is contraindicated or logistically delayed and can track response to thrombolysis/anticoagulation, informing escalation or de-escalation decisions.
Key Findings
- EIT-derived wasted-ventilation index achieved AUC 0.989 in animal models and 0.923 in patients for detecting pulmonary arterial occlusions.
- Strong agreement of regional perfusion between EIT and DCE-CT (mean bias −3.04%±3.02) and between EIT and CTPA (+3.45%±2.81).
- Index distinguished occlusive PE from non-occlusive perfusion impairments and decreased consistently after thrombolysis.
Methodological Strengths
- Multimodal validation against DCE-CT and quantitative CTPA in both animal and human cohorts.
- Demonstrated therapeutic responsiveness (post-thrombolysis decline) supporting clinical utility.
Limitations
- Clinical patient sample size was moderate and settings were specialized; broader external validation is needed.
- Not a randomized outcome study; impact on clinical decision-making and patient-centered outcomes remains to be proven.
Future Directions: Prospective multicenter trials to test EIT-guided diagnostic and treatment algorithms for suspected PE, including outcome effects and resource utilization.
BACKGROUND: Timely detection of pulmonary embolism (PE) is crucial, particularly in critical settings where rapid confirmation or exclusion is required and computerized tomography pulmonary angiography (CTPA) poses safety challenges. We assessed the experimental and clinical accuracy of electrical impedance tomography (EIT)-ventilation-perfusion (V̇/Q̇) maps and a novel wasted-ventilation index for detecting PE. METHODS: Ten piglets underwent EIT-V̇/Q̇ mapping before and after proximal or distal pulmonary artery occlusions. EIT-perfusion maps were validated against dynamic contrast-enhanced CT (DCE-CT) and quantitative clot-burden analysis from whole-lung CTPA. To assess specificity, models of non-occlusive perfusion impairment were added (6 piglets). The wasted-ventilation index was refined across 114 piglet conditions (66 PE) and subsequently validated in 66 patients with acute respiratory failure (257 exams) and 10 patients with chronic thromboembolic disease (31 exams), totaling 288 EIT-exams. RESULTS: Strong positive correlations between estimates of regional perfusion obtained by EIT vs. DCE-CT or CTPA were found. Agreement showed mean bias of - 3.04 ± 3.02% between EIT and DCE-CT, and + 3.45 ± 2.81% between EIT and CTPA. The wasted-ventilation index performed with AUC = 0.989 in animals (P < 0.0001; sensitivity 96%, specificity 94%) and AUC = 0.923 in patients (P < 0.001; sensitivity 81%, specificity 94%). The index consistently decreased after thrombolysis. CONCLUSIONS: The novel wasted-ventilation index showed high accuracy in detecting pulmonary arterial occlusions of varying severity, distinguishing them from other perfusion problems. Its agreement with CTPA, DCE-CT, and reference methods supports EIT-V̇/Q̇ mapping as a reliable diagnostic aid when conventional imaging is unfeasible or risky.
2. Fine particulate matter exposure and Cystic Fibrosis morbidity in the age of CFTR modulators, an observational study.
In a 5,661-person registry cohort, greater long-term PM2.5 exposure correlated with lower FEV1/FVC, higher exacerbation rates, and earlier acquisition of P. aeruginosa and MRSA. CFTR modulators attenuated pollution-related decrements in lung function but did not mitigate the association with exacerbations.
Impact: Links ambient air pollution to CF morbidity in the modulator era with effect-modification by CFTR modulators, informing both clinical counseling and public health policy.
Clinical Implications: CF care should incorporate environmental risk counseling (e.g., air quality alerts, indoor filtration, exposure reduction), recognizing that CFTR modulators do not fully offset pollution-related exacerbation risk.
Key Findings
- Each 10-percentage-point increase in days with PM2.5 ≥12 μg/m3 was associated with −0.82 ppFEV1 and −0.97 ppFVC (both P<0.0001).
- Pulmonary exacerbation rates rose by 6.7% per 10-percentage-point increase in high-PM2.5 days (P=0.0014).
- Higher PM2.5 predicted earlier Pseudomonas aeruginosa and MRSA acquisition; CFTR modulators attenuated lung function decrements but not exacerbation associations.
Methodological Strengths
- Large national registry linkage (N=5,661) with daily ZIP code-level PM2.5 exposure and multi-model statistical framework.
- Formal interaction analysis testing effect modification by CFTR modulator use.
Limitations
- Exposure misclassification potential due to ZIP code-level estimates rather than personal monitoring.
- Observational design cannot exclude residual confounding; generalizability may vary by geography and pollution mix.
Future Directions: Prospective studies incorporating personal exposure monitoring and intervention trials (e.g., indoor filtration) to test strategies that mitigate pollution-related CF morbidity in the modulator era.
RATIONALE: Despite CFTR modulators transforming cystic fibrosis (CF) care, patients still show wide variability in pulmonary outcomes. The contribution of ambient fine particulate matter (PM2.5) exposure to this variability in the modulator era is unknown. OBJECTIVES: To quantify the effects of PM2.5 on pulmonary outcomes in people with CF and to assess whether CFTR modulator use modifies these effects. METHODS: In a retrospective cohort of 5,661 from the Cystic Fibrosis Foundation Registry, ZIP codes were linked to daily PM2.5. Long-term exposure was defined as the fraction of days ≥ 12 µg/m3 from birth to spirometry. Linear mixed-effects models assessed lung function, negative binomial regression estimated exacerbation counts, and Cox proportional hazards models evaluated time to pathogen acquisition. Interaction terms tested modification by CFTR modulator use. RESULTS: Each 10 percentage-point increase fraction of long-term days ≥ 12 µg/m3 (range 0% to 88%) was associated with an 0.82-point decrease in precent predicted FEV1 (95% CI -1.07 to -0.56; P < .0001) and a 0.97-point decrease in FVC % predicted (95% CI -1.20 to -0.73; P < .0001). Similarly, pulmonary exacerbation rates increased by 6.7% (95% CI 2.55-11.1; P = .0014). Higher PM2.5 also predicted earlier P. aeruginosa and MRSA positivity. CFTR modulators significantly attenuated PM2.5-related decrements in lung function but no significant interactions regarding pulmonary exacerbations were identified. CONCLUSIONS: Long-term PM2.5 exposure remains a strong predictor of lung function, pulmonary exacerbations, and bacterial pathogen acquisition. While CFTR modulators appeared to mitigate the association between PM2.5 exposure and lung function, no such mitigation was identified in relationship to pulmonary exacerbations.
3. Artificial Intelligence Algorithm to Monitor Inspiratory Muscle Effort and Patient-Ventilator Dyssynchrony During Mechanical Ventilation.
A prospective ICU study showed that a noninvasive AI algorithm can estimate inspiratory muscle pressure with small bias versus esophageal manometry and detect key dyssynchronies with high sensitivity and moderate specificity. Performance was comparable to occlusion-based intermittent techniques while enabling continuous, breath-by-breath monitoring.
Impact: Provides a practical, noninvasive, real-time monitoring solution for patient effort and synchrony—parameters central to lung- and diaphragm-protective ventilation strategies.
Clinical Implications: Continuous AI-derived Pmus and dyssynchrony detection could guide individualized titration of pressure support, sedation, and trigger settings, potentially reducing ventilator-induced lung and diaphragm injury.
Key Findings
- Noninvasive AI Pmus estimation showed a bias of 0.9 cmH2O vs. esophageal manometry with 95% limits of agreement of −5.1 to 6.9 cmH2O.
- Detection of extreme Pmus and dynamic driving pressure achieved AUC > 0.8.
- Automatic dyssynchrony detection (ineffective efforts, autotriggering, reverse triggering) had sensitivity 86.5% and specificity 77.4%.
Methodological Strengths
- Prospective diagnostic accuracy design with gold-standard comparison (esophageal manometry).
- Large number of analyzed breaths (4,918 cycles) enabling robust breath-by-breath evaluation.
Limitations
- Single health system with two ICUs; broader multicenter external validation is needed.
- Algorithm performance in other ventilatory modes and deeply sedated or paralyzed patients remains to be established.
Future Directions: Multicenter trials to assess clinical impact of AI-guided ventilator adjustments on outcomes (e.g., ventilator-free days, diaphragm function) and integration into ventilator platforms.
OBJECTIVE: Current methods for estimating inspiratory muscle pressure (Pmus) during mechanical ventilation are either invasive or dependent on occlusion maneuvers. A noninvasive artificial intelligence (AI) algorithm estimating in real-time the amplitude and timing of Pmus, enabling continuous monitoring of patient effort, driving pressure, and synchrony with the ventilator was designed, and its performance was evaluated against the gold standard obtained with esophageal manometry (Pmus,es). DESIGN: A prospective diagnostic accuracy study. SETTING: Two ICUs from the University of São Paulo, Brazil. PATIENTS: Adult patients under pressure support ventilation. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Pmus estimated using AI (Pmus,AI) was compared with Pmus,es and to values derived from occlusion maneuvers, the pressure muscle index and the occlusion pressure (Pocc). Automatic detection of dyssynchronies based on Pmus,AI was compared with experts' classification. A total of 48 participants with 4918 cycles were analyzed. Pmus,es varied from 1.0 to 28.4 cm H2O. Pmus,AI showed a bias of 0.9 cm H2O, 95% limits of agreement -5.1, 6.9 cm H2O and detected extreme values of both Pmus,es and dynamic driving pressure with area under the receiver operating characteristic curve greater than 0.8. Pmus,AI accuracy was comparable to occlusion-based techniques. Sensitivity and specificity to detect ineffective effort, autotriggering or reverse triggering were 86.5% and 77.4%, respectively. CONCLUSIONS: AI presented good performance in detecting high and low Pmus, and allowed the automatic detection of specific types of dyssynchronies. This novel noninvasive method was comparable to intermittent techniques requiring occlusion maneuvers.